Nebius stock is experiencing a downward slide today. Further details regarding the specific drivers behind the tumble have not yet been provided.
Strong patient demand for generic medications and specialty therapeutics drove robust profit growth, prompting leadership to boost its full-year earnings guidance. A high-performing pharmaceutical core offset persistent weakness in secondary logistics and supply divisions. Consequently, the healthcare distributor's shares advanced over 3% amid a wider market retreat.
Public sector undertakings and major technology corporations are driving significant cash returns for domestic equity investors through sustained high dividend distributions. While these regular payouts offer substantial yields relative to current share prices, underlying capital appreciation varies widely across the featured businesses. Consequently, strong cash distributions have partially offset share price declines for certain state-run firms, while technology and energy leaders managed to pair payouts with po…
Democratic victories in the U.S. midterm elections have triggered widespread regulatory concerns across the artificial intelligence sector, prompting severe sell-offs in major tech equities. Markets are reacting sharply to political shifts, particularly after significant political investments failed to prevent local opposition to critical computing infrastructure. This unexpected electoral outcome has intensified broader fears that AI valuations are due for a substantial market correction.